BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 28095852)

  • 21. COPD Assessment Test for measurement of health status in patients with idiopathic pulmonary fibrosis: A cross-sectional study.
    Matsuda T; Taniguchi H; Ando M; Kondoh Y; Kimura T; Kataoka K; Sakamoto K; Suzuki A; Furukawa T; Hasegawa Y
    Respirology; 2017 May; 22(4):721-727. PubMed ID: 27859913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health-related quality of life in idiopathic pulmonary fibrosis: Data from the Australian IPF Registry.
    Glaspole IN; Chapman SA; Cooper WA; Ellis SJ; Goh NS; Hopkins PM; Macansh S; Mahar A; Moodley YP; Paul E; Reynolds PN; Walters EH; Zappala CJ; Corte TJ
    Respirology; 2017 Jul; 22(5):950-956. PubMed ID: 28166611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association between health-related quality of life and disease progression in idiopathic pulmonary fibrosis: a prospective cohort study.
    Akihiko S; Tomohiro H; Toru O; Kiminobu T; Kohei I; Yoshinari N; Takeshi K; Kumiko K; Kazuo C; Michiaki M
    Sarcoidosis Vasc Diffuse Lung Dis; 2017; 34(3):226-235. PubMed ID: 32476850
    [No Abstract]   [Full Text] [Related]  

  • 24. Association between six-minute walk test parameters and the health-related quality of life in patients with pulmonary Mycobacterium avium complex disease.
    Yagi K; Asakura T; Namkoong H; Suzuki S; Asami T; Okamori S; Kusumoto T; Funatsu Y; Kamata H; Nishimura T; Ishii M; Betsuyaku T; Hasegawa N
    BMC Pulm Med; 2018 Jul; 18(1):114. PubMed ID: 30005658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality of Life and Healthcare Resource Use in a Real-world Patient Population with Idiopathic Pulmonary Fibrosis: The PROOF Registry.
    Wuyts WA; Dahlqvist C; Slabbynck H; Schlesser M; Gusbin N; Compere C; Maddens S; Rizzo S; Kirchgaessler KU; Bartley K; Bondue B
    Pulm Ther; 2022 Jun; 8(2):181-194. PubMed ID: 35429319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-sectional and longitudinal construct validity of the Saint George's Respiratory Questionnaire in patients with IPF.
    Peng S; Li Z; Kang J; Hou X
    Respirology; 2008 Nov; 13(6):871-9. PubMed ID: 18811886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The UCSD shortness of breath questionnaire has longitudinal construct validity in idiopathic pulmonary fibrosis.
    Swigris JJ; Han M; Vij R; Noth I; Eisenstein EL; Anstrom KJ; Brown KK; Fairclough D
    Respir Med; 2012 Oct; 106(10):1447-55. PubMed ID: 22801586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short- and long-term effects of pulmonary rehabilitation for idiopathic pulmonary fibrosis: a systematic review and meta-analysis.
    Cheng L; Tan B; Yin Y; Wang S; Jia L; Warner G; Jia G; Jiang W
    Clin Rehabil; 2018 Oct; 32(10):1299-1307. PubMed ID: 29843523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anxiety and depression status in patients with idiopathic pulmonary fibrosis and outcomes of nintedanib treatment: an observational study.
    He X; Ji J; Pei Z; Luo Z; Fang S; Liu X; Lei Y; Yan H; Guo L
    Ann Med; 2024 Dec; 56(1):2323097. PubMed ID: 38581666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cell profiles of bronchoalveolar lavage fluid as prognostic indicators of idiopathic pulmonary fibrosis].
    Peng SC; Li ZH; Kang J; Hou XM; Yu RJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Apr; 31(4):260-3. PubMed ID: 18846961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depression Is Significantly Associated with the Health Status in Patients with Idiopathic Pulmonary Fibrosis.
    Matsuda T; Taniguchi H; Ando M; Kondoh Y; Kimura T; Kataoka K; Nishimura K; Nishiyama O; Sakamoto K; Hasegawa Y
    Intern Med; 2017; 56(13):1637-1644. PubMed ID: 28674350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis.
    Kolb M; Raghu G; Wells AU; Behr J; Richeldi L; Schinzel B; Quaresma M; Stowasser S; Martinez FJ;
    N Engl J Med; 2018 Nov; 379(18):1722-1731. PubMed ID: 30220235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thalidomide for the treatment of cough in idiopathic pulmonary fibrosis: a randomized trial.
    Horton MR; Santopietro V; Mathew L; Horton KM; Polito AJ; Liu MC; Danoff SK; Lechtzin N
    Ann Intern Med; 2012 Sep; 157(6):398-406. PubMed ID: 22986377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health-related quality of life and 6 min walk distance in patients with idiopathic pulmonary fibrosis.
    Verma G; Marras T; Chowdhury N; Singer L
    Can Respir J; 2011; 18(5):283-7. PubMed ID: 21969931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The COPD assessment test and St George's Respiratory Questionnaire: are they equivalent in subjects with COPD?
    Morishita-Katsu M; Nishimura K; Taniguchi H; Kimura T; Kondoh Y; Kataoka K; Ogawa T; Watanabe F; Arizono S; Nishiyama O; Nakayasu K; Imaizumi K; Hasegawa Y
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1543-51. PubMed ID: 27462150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Prognostic Role of Ventilatory Inefficiency and Exercise Capacity in Idiopathic Pulmonary Fibrosis.
    Vainshelboim B; Oliveira J; Fox BD; Kramer MR
    Respir Care; 2016 Aug; 61(8):1100-9. PubMed ID: 27165419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis.
    Oda K; Yatera K; Fujino Y; Kido T; Hanaka T; Sennari K; Fushimi K; Matsuda S; Mukae H
    Respir Investig; 2018 Jan; 56(1):64-71. PubMed ID: 29325684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term effects of a 12-week exercise training program on clinical outcomes in idiopathic pulmonary fibrosis.
    Vainshelboim B; Oliveira J; Fox BD; Soreck Y; Fruchter O; Kramer MR
    Lung; 2015 Jun; 193(3):345-54. PubMed ID: 25731736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A bundled care approach to patients with idiopathic pulmonary fibrosis improves transplant-free survival.
    Kulkarni T; Willoughby J; Acosta Lara Mdel P; Kim YI; Ramachandran R; Alexander CB; Luckhardt T; Thannickal VJ; de Andrade JA
    Respir Med; 2016 Jun; 115():33-8. PubMed ID: 27215501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and Initial Validation Analyses of the Living with Idiopathic Pulmonary Fibrosis Questionnaire.
    Swigris JJ; Andrae DA; Churney T; Johnson N; Scholand MB; White ES; Matsui A; Raimundo K; Evans CJ
    Am J Respir Crit Care Med; 2020 Dec; 202(12):1689-1697. PubMed ID: 32634038
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.